High B3GALT5 expression confers poor clinical outcome and contributes to tumor progression and metastasis in breast cancer

BACKGROUND: Existence of breast cancer stem cells (BCSCs) is implicated in disease relapse, metastasis, and resistance of treatment. β1,3-Galactosyltransferase 5 (B3GALT5) has been shown to be a pro-survival marker for BCSCs. However, little is known about the prognostic significance of B3GALT5 in b...

Descripción completa

Detalles Bibliográficos
Autores principales: Liao, Yu-Mei, Wang, Ya-Hui, Hung, Jung-Tung, Lin, Yu-Ju, Huang, Yen-Lin, Liao, Guo-Shiou, Hsu, Ya-Ling, Wu, Jen-Chien, Yu, Alice L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7792347/
https://www.ncbi.nlm.nih.gov/pubmed/33413566
http://dx.doi.org/10.1186/s13058-020-01381-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7792347/
https://www.ncbi.nlm.nih.gov/pubmed/33413566
http://dx.doi.org/10.1186/s13058-020-01381-9

Ejemplares similares